复星医药(02196.HK)子公司治疗抗结核新药注册申请获批

阿斯达克财经04-25

复星医药(02196.HK) 公布，控股子公司沈阳红旗制药自主研发的环丝氨酸胶囊，用于对该药敏感的结核菌引起且经一线抗结核药治疗效果不佳的活动性肺结核和肺外结核治疗的上市注册申请获国家药品监督管理局批准。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-24 16:25。)

AASTOCKS新闻

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2430465477?lang=zh_CN&edition=full","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190604131519775_s.jpg","is_english":false,"pubTime":"2024-04-25 00:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2430465477","market":"hk","top_or_hot":-1,"title":"复星医药(02196.HK)子公司治疗抗结核新药注册申请获批","media":"阿斯达克财经","content":"<html><body><div> <span> <p><a href=\"https://laohu8.com/S/600196\">复星医药</a>(02196.HK)<span> </span>公布，控股子公司沈阳红旗制药自主研发的环丝氨酸胶囊，用于对该药敏感的结核菌引起且经一线抗结核药治疗效果不佳的活动性肺结核和肺外结核治疗的上市注册申请获国家药品监督管理局批准。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-24 16:25。)<br/><span></span><br/></p><div></div>AASTOCKS新闻 </span> </div></body></html>","source":"aastocks_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>复星医药(02196.HK)子公司治疗抗结核新药注册申请获批</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n复星医药(02196.HK)子公司治疗抗结核新药注册申请获批\n</h2>\n\n<h4 class=\"meta\">\n\n<p class=\"head\">\n<strong class=\"h-name small\">阿斯达克财经</strong><span class=\"h-time small\">2024-04-25 00:30</span>\n</p>\n\n</h4>\n\n</header>\n<article>\n<html><body><div> <span> <p><a href=\"https://laohu8.com/S/600196\">复星医药</a>(02196.HK)<span> </span>公布，控股子公司沈阳红旗制药自主研发的环丝氨酸胶囊，用于对该药敏感的结核菌引起且经一线抗结核药治疗效果不佳的活动性肺结核和肺外结核治疗的上市注册申请获国家药品监督管理局批准。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-24 16:25。)<br/><span></span><br/></p><div></div>AASTOCKS新闻 </span> </div></body></html>\n\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1344772/latest-news/AAFN\">阿斯达克财经</a> </p>\n\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n</div>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0183","symbol_name":"MSCI概念","start_time":0,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1344772/latest-news/AAFN","article_id":"2430465477","we_media_id":null,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190604131519775_s.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2430465477","pubTimestamp":1713976200,"sourceInfo":{"source_id":"aastocks_highlight","name":"阿思達克財經"},"weMediaInfo":null,"summary":"复星医药(02196.HK) 公布，控股子公司沈阳红旗制药自主研发的环丝氨酸胶囊，用于对该药敏感的结核菌引起且经一线抗结核药治疗效果不佳的活动性肺结核和肺外结核治疗的上市注册申请获国家药品监督管理局批准。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-24 16:25。)AASTOCKS新闻","collect":0,"end_time":0,"defaultTopTitle":"aastocks.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600196":"复星医药","BK0183":"MSCI概念","BK0060":"抗癌","BK0187":"一线龙头","BK0012":"证金概念","02196":"复星医药","BK0196":"行业龙头","BK0239":"医药制造","BK0188":"融资融券","BK1515":"抗疫概念","BK1191":"制药","BK1593":"医美概念股","BK0175":"白马股","BK0096":"民营医院","BK0028":"国家队"},"translate_title":"Fosun Pharma (02196. HK) Subsidiary Approved for New Drug Registration Application for Anti-tuberculosis Treatment","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600196":1,"02196":1},"content_text":"复星医药(02196.HK) 公布，控股子公司沈阳红旗制药自主研发的环丝氨酸胶囊，用于对该药敏感的结核菌引起且经一线抗结核药治疗效果不佳的活动性肺结核和肺外结核治疗的上市注册申请获国家药品监督管理局批准。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-24 16:25。)AASTOCKS新闻","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2430465477"}